Company Analysis
Sign in

Absci Corporation (ABSI)

Nasdaq: ABSI · Services-Commercial Physical & Biological Research · Vancouver, WA · filing with the SEC since 2016
Full chart Alerts Compare
Grade3.9
◀ Past 3.8● Present 4.1▶ Future 3.8
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

11 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Absci Corporation’s names, not what it holds today.

Patents granted
11
11 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against 2 in 2024 and 1 in 2023
Applications published
34
10 of them in 2025
Names they are printed under
3
its own name, a subsidiary
By yearGrantedApplications published
'15'16'17'18'19'20'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology7
Computer technology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name3 counted
ABSCI CORPORATION its own name
named as the applicant on its applications, in US
0 granted
23 published
ABSCI CORPORATION its own name
US, as the owner printed on each patent
11 granted
9 published
Target Discovery Merger Sub II, LLC a subsidiary
named as the applicant on its applications, in US
0 granted
2 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Nov 18, 202512,473,370TL1A associated antibody compositions and methods of useComputer technologyABSCI CORPORATION
Apr 29, 202512,285,484Cancer associated antibody compositions and methods of useBiotechnologyABSCI CORPORATION
Dec 3, 202412,157,766Cytoplasmic expression systemBiotechnologyABSCI CORPORATION
Nov 5, 202412,134,655Cancer associated antibody compositions and methods of useBiotechnologyABSCI CORPORATION
Feb 21, 202311,584,785C-peptides and proinsulin polypeptides comprising the sameBiotechnologyABSCI CORPORATION
Sep 20, 202211,447,781Host cells for use in an inducible coexpression systemBiotechnologyABSCI CORPORATION
Jun 28, 202211,371,048Vectors for use in an inducible coexpression systemBiotechnologyABSCI CORPORATION
Jan 4, 202211,214,807Methods for inducible expression of polypeptidesBiotechnologyABSCI CORPORATION
Mar 31, 202010,604,761Host cells for use in an inducible coexpression systemBiotechnologyABSCI CORPORATION
Dec 17, 201910,508,270Coordinated coexpression of thrombinBiotechnologyABSCI CORPORATION
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 18, 20252025/0383346AFFINITY SCREENING METHODAnalysis of biological materialsABSCI CORPORATION
Jul 3, 20252025/0218531UNLOCKING DE NOVO ANTIBODY DESIGN WITH GENERATIVE ARTIFICIAL INTELLIGENCEComputer technologyABSCI CORPORATION
Apr 3, 20252025/0109210TL1A ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USEComputer technologyABSCI CORPORATION · patent 12,473,370 granted from it
Apr 3, 20252025/0109209TL1A ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USEComputer technologyABSCI CORPORATION
Mar 27, 20252025/0104804SYSTEMS AND METHODS OF DEVELOPING DISEASE ASSOCIATED ANTIBODY SEQUENCESComputer technologyABSCI CORPORATION
Mar 20, 20252025/0092155CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USEBiotechnologyABSCI CORPORATION
Feb 20, 20252025/0059259KNOCKOUT OF ptsP GENE ELEVATES ACTIVE GENE EXPRESSIONBiotechnologyABSCI CORPORATION
Feb 13, 20252025/0051823PRODUCTS AND METHODS FOR HETEROLOGOUS EXPRESSION OF PROTEINS IN A HOST CELLBiotechnologyABSCI CORPORATION
Feb 13, 20252025/0051760SOLID-PHASE SCREENING FOR HIGH-PERFORMING BACTERIAL STRAINSBiotechnologyABSCI CORPORATION
Feb 13, 20252025/0051758FolA Selection Assay to Identify Strains with Increased Soluble Target Protein ExpressionBiotechnologyABSCI CORPORATION
What it applied for, 2024 to 2025: Biotechnology 6 · Computer technology 4 · Analysis of biological materials 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton ABSI · research, not advice